Gut Microbiome Biomarkers for Disease Diagnosis 2023

The publication ‘The Microbiologist’ provides detailed information on the latest research, reviews, events, and news on a wide variety of microbiological topics. The Microbiologist has recently published an article written by our Scientific Content Writer Dr. Madeleine Ball and our Senior Biomarker Scientist Dr. Hsuan (Tina) Chou, highlighting how gut microbiome biomarkers can be analyzed in breath for a non-invasive approach to studying the microbiome.

Breath and the Microbiome.

The article, titled ‘A Gateway to Health: Harnessing Gut Microbiome Biomarkers in Breath for Disease Diagnosis and Monitoring’, discusses how exhaled breath contains volatile organic compounds (VOCs) that have been produced by the gut microbiota. The article highlights what compounds can be found in the breath, as well as the wide range of advantages breath has in comparison to other sampling mediums. These benefits include the fact that breath is a virtually inexhaustible resource that is continually produced, is non-invasive, easy to use, and a large volume of breath can be collected at any one time.

‘We are still at the beginning of appreciating the multitude of roles that the gut microbiota plays in the maintenance of our health and the development of disease. Breath analysis remains an underutilized tool in clinical research and practice, with immense potential to enhance our understanding of the gut microbiome.’

Owlstone Medical is the world leader in breath analysis, and we can help you incorporate breath into your research. Our Breath Biopsy® technology can be used for the identification and discovery of disease-originating biomarkers. If you are interested in using breath analysis in your research or have any questions, please get in touch.